7-81974555-GAAAA-GAAAAAA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000722.4(CACNA2D1):c.1956-5_1956-4dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0775 in 1,342,172 control chromosomes in the GnomAD database, including 3,164 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.092 ( 630 hom., cov: 30)
Exomes 𝑓: 0.076 ( 2534 hom. )
Consequence
CACNA2D1
NM_000722.4 splice_region, intron
NM_000722.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.195
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 7-81974555-G-GAA is Benign according to our data. Variant chr7-81974555-G-GAA is described in ClinVar as [Benign]. Clinvar id is 215475.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.108 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA2D1 | NM_000722.4 | c.1956-5_1956-4dupTT | splice_region_variant, intron_variant | ENST00000356860.8 | NP_000713.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.1956-5_1956-4dupTT | splice_region_variant, intron_variant | 1 | NM_000722.4 | ENSP00000349320.3 | ||||
CACNA2D1 | ENST00000443883.2 | c.1992-5_1992-4dupTT | splice_region_variant, intron_variant | 5 | ENSP00000409374.2 | |||||
CACNA2D1 | ENST00000705962.1 | c.1836-5_1836-4dupTT | splice_region_variant, intron_variant | ENSP00000516190.1 | ||||||
CACNA2D1 | ENST00000705961.1 | c.1722-5_1722-4dupTT | splice_region_variant, intron_variant | ENSP00000516189.1 |
Frequencies
GnomAD3 genomes AF: 0.0923 AC: 13610AN: 147442Hom.: 631 Cov.: 30
GnomAD3 genomes
AF:
AC:
13610
AN:
147442
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0885 AC: 17192AN: 194206Hom.: 446 AF XY: 0.0857 AC XY: 9015AN XY: 105240
GnomAD3 exomes
AF:
AC:
17192
AN:
194206
Hom.:
AF XY:
AC XY:
9015
AN XY:
105240
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0756 AC: 90358AN: 1194648Hom.: 2534 Cov.: 18 AF XY: 0.0749 AC XY: 45272AN XY: 604160
GnomAD4 exome
AF:
AC:
90358
AN:
1194648
Hom.:
Cov.:
18
AF XY:
AC XY:
45272
AN XY:
604160
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0923 AC: 13615AN: 147524Hom.: 630 Cov.: 30 AF XY: 0.0901 AC XY: 6466AN XY: 71738
GnomAD4 genome
AF:
AC:
13615
AN:
147524
Hom.:
Cov.:
30
AF XY:
AC XY:
6466
AN XY:
71738
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Apr 14, 2015 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 11, 2018 | - - |
Brugada syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at